WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...
The findings revealed a potential link between the use of these drugs and an increased risk of Parkinson’s disease. The risk ...
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...
which are types of white blood cells. This suggests that the previously reported relationship between mtDNA–CN and Parkinson's is linked by immune responses in blood, instead of mitochondrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results